RedHill Biopharma Ltd.
SPHINGOSINE KINASE 2 INHIBITOR FOR TREATING CORONAVIRUS INFECTION
Last updated:
Abstract:
The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.
Status:
Application
Type:
Utility
Filling date:
15 Oct 2021
Issue date:
3 Feb 2022